Biopharma Business

Tag "deal"

Perrigo sells Tysabri rights to Royalty Pharma in €2.7bn deal

Irish consumer healthcare and generic drug group Perrigo said has agreed to sell the royalty stream from its multiple sclerosis drug Tysabri to another Irish group, privately held Royalty Pharma,

Read Full Article

Upcoming Events


The Magazine

New Subscriber

Subscribe Here